Francisco Partners Agrees to Acquire Weave for About $650M

Weave has entered a definitive agreement to be acquired by Francisco Partners in an all-cash transaction with an aggregate equity value of approximately $650M.

Weave stockholders would receive $7.40 per share, representing an approximately 34% premium to the company's unaffected closing share price on August 17, 2026. The transaction is expected to close in the fourth quarter of 2026, subject to shareholder approval, regulatory clearance, and customary closing conditions.

The agreement is signed, not completed. Weave remains a public company until the conditions are satisfied and the transaction closes. That distinction matters because the operating thesis begins after the premium and purchase price have done their work.

What Francisco Partners Agreed to Acquire

Weave announced the definitive agreement on August 18, 2026. Francisco Partners will acquire all outstanding shares for $7.40 in cash, valuing Weave's equity at approximately $650M.

The purchase price represents a premium of approximately 34% to the unaffected closing price on August 17. The agreement includes customary provisions around shareholder voting, regulatory review, representations, covenants, and closing conditions.

Weave has not yet changed ownership. Shareholders must approve the transaction, and regulators must complete the applicable review. The expected fourth-quarter closing date is a target rather than a completed milestone.

What Weave Does

Weave provides customer-experience and payments software for small and medium-sized healthcare practices. Its platform combines phone and messaging, scheduling, reminders, reviews, payments, and revenue-cycle workflows.

The company says more than 40,000 healthcare locations use the platform. That is company-reported adoption rather than an independently audited market-share figure, but it shows the scale of the workflow Francisco Partners is acquiring.

For a dental, veterinary, optometry, or medical practice, the product sits between patient communication and revenue collection. A missed call can become a missed appointment. A scheduling problem can become unused capacity. A payment or insurance issue can become delayed cash flow.

That operating position is attractive because communication, scheduling, and payments reinforce one another. It is also unforgiving because the customer experiences every failure as part of the same practice day, regardless of which software module caused it.

Why Francisco Partners Wants Weave

Francisco Partners has spent decades investing in technology businesses, including vertical and healthcare software companies. The firm is led in this transaction by partners including Ezra Perlman and Nick Nelson.

The acquisition thesis is that Weave can expand its role inside the practice by investing more deeply in AI, payments, revenue-cycle management, and connected workflows. Private ownership can give the company a different planning horizon and a more concentrated owner, but it does not automatically create better products or faster execution.

The most valuable opportunity is not adding modules for the sake of a larger software bundle. It is reducing the number of handoffs that a practice must manage between patient communication, staff workflow, and getting paid.

An integrated platform creates operating leverage only if the integration is real. If products remain loosely connected beneath one contract, the customer is still the middleware.

What the Deal Means for Weave Shareholders

If the transaction closes, shareholders will receive $7.40 in cash for each share and Weave will become a privately held company. The 34% premium gives public investors a defined price relative to the unaffected market value.

The equity-value figure is not the same as the buyer's complete enterprise-value economics. The announcement centers on approximately $650M of aggregate equity value and does not provide every financing, fee, cash, debt, or transaction-cost detail required to reconstruct the buyer's full capital structure.

Shareholders also retain closing risk until the approvals and conditions are completed. The premium compensates investors for giving up future participation, but the transaction still depends on a successful vote, regulatory clearance, and the absence of events that would prevent closing under the agreement.

What Private Ownership Changes

Weave CEO Brett White described the transaction as an opportunity to accelerate the company's mission and deepen investment in the platform. A private-company structure can reduce the pressure of quarterly public-market expectations and make it easier to prioritize a multiyear product or operating plan.

That room comes with a new form of pressure. Francisco Partners will expect Weave to convert product investment into growth, retention, margins, and durable customer value. Private ownership changes the scoreboard. It does not remove one.

The company also has to preserve customer trust during the transition. Healthcare practices depend on the system for daily communication and payments, so integration plans, staffing decisions, pricing, and product changes will matter long before the acquisition thesis can be measured in an exit.

What Comes Next

The immediate milestones are Weave's shareholder vote, regulatory review, and the expected closing in the fourth quarter of 2026. After closing, the evidence shifts to product execution, customer retention, payments growth, revenue-cycle adoption, and whether Francisco Partners can help Weave expand without making the platform more complicated for the practices it serves.

The $650M agreement answers what public shareholders may receive if the transaction closes. Going private gives Weave a different owner, a different clock, and a new obligation to prove that deeper control of the workflow becomes better execution.

The premium settles one question. What Weave builds with the room it creates will answer the one that matters next.